Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From design to biological mechanism evaluation of phenylalanine-bearing HIV-1 capsid inhibitors targeting a vital assembly interface
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 3, pp. 107611-107611
Closed Access | Times Cited: 12

Showing 12 citing articles:

Asymmetric Construction of α,α‐Disubstituted Piperazinones Enabled by Benzilic Amide Rearrangement
Yu‐Ping He, Rui Quan, Xing‐Zi Li, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 18
Closed Access | Times Cited: 17
Nucleoside antiviral agents with atypical structures and new targets
Hui Xu, B. Li, Kai Tang, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130110-130110
Closed Access
Twice-yearly Lenacapavir demonstrated exceptional efficacy for HIV prevention
Shujing Xu, Peng Zhan
The Innovation (2024) Vol. 5, Iss. 5, pp. 100683-100683
Open Access | Times Cited: 3
State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics
S Ravichandran, William M. McFadden, Alexa A. Snyder, et al.
Global Health & Medicine (2024)
Closed Access | Times Cited: 3
Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization
Lanlan Jing, Gaochan Wu, Fabao Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116772-116772
Closed Access | Times Cited: 2
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
Shujing Xu, Lin Sun, Michael J. Barnett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16303-16329
Open Access | Times Cited: 5
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1272-1295
Open Access | Times Cited: 4
The latest developments in the design and discovery of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV
Junyi Li, Bing Ye, Shenghua Gao, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-18
Closed Access | Times Cited: 1
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7640-7640
Open Access | Times Cited: 7
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8415-8415
Open Access | Times Cited: 5
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor
Shaoqing Du, Xinyong Liu, Xueping Hu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Asymmetric Construction of α,α‐Disubstituted Piperazinones Enabled by Benzilic Amide Rearrangement
Yu‐Ping He, Rui Quan, Xing‐Zi Li, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 18
Closed Access
Page 1

Scroll to top